At Luna Mare Capital, we are pioneering a data-driven approach to biopharma investment, harnessing artificial intelligence to generate insights that transcend conventional analysis. Our recent advancements have significantly elevated our investment process, and we’re excited to share how this translates into tangible advantages for our portfolio.